Ailene Marie Staples, NP
Nurse Practitioner · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 6 years
- Graduated 2020
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Ochsner Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Ailene Marie Staples’s office at (650) 723-4000 to ask if they take your plan before you enroll.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Ochsner Medical Center AcuteNew Orleans, LAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Ochsner Health System, which runs 36 hospitals in 3 statesPatients rate it 3 of 5 · 72% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Pressure ulcer rate: 1.34 (0.89 to 1.8) · 9,200 cases, Jul 2022 – Jun 2024Worse than the national rate — SSI - Abdominal Hysterectomy: 3.744, Oct 2024 – Sep 2025Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.212, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.298, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.176, Oct 2024 – Sep 2025Better than the national rate — Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies): 9.9 (7.9 to 12.4) · 3,298 cases, Jan 2022 – Dec 2024
See every measure and the patient survey for Ochsner Medical Center Acute
Behind the star rating — Deaths: 2 better, 5 the same, 1 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 6 the same, 3 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Pressure ulcer rateComplications and deaths | 1.34 (0.89 to 1.8) · 9,200 cases | Worse | Jul 2022 – Jun 2024 |
| SSI - Abdominal HysterectomyInfections | 3.744 | Worse | Oct 2024 – Sep 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.212 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.298 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.176 | Better | Oct 2024 – Sep 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 9.9 (7.9 to 12.4) · 3,298 cases | Better | Jan 2022 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.86 (0.07 to 1.65) · 2,712 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.15 (0.93 to 1.37) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 173.07 (136.7 to 209.45) · 172 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 50 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 10.1 · 123 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.1 · 159 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.6 · 596 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.2 · 419 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.3 · 878 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.4 · 8,405 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.21 (0.03 to 0.39) · 10,838 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.18 (0 to 0.36) · 11,193 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.65 (1.04 to 4.27) · 3,022 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.27 (0.1 to 2.45) · 1,392 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 3.06 (1.92 to 4.21) · 2,824 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.85 (5.53 to 14.16) · 1,336 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.94 (2.4 to 7.48) · 1,367 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.87 (1.55 to 4.2) · 893 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.4 · 72 cases | None | Apr 2023 – Mar 2025 |
| MRSA BacteremiaInfections | 0.742 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.112 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.2 · 606 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.7 · 2,168 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 24.2 · 192 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 24.2 · 724 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 31.3 · 443 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.5 · 1,209 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.4 (5.1 to 8.1) · 663 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.6 (7.9 to 11.7) · 663 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 64 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 13.3 · 116 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.4 · 603 cases | None | Jul 2023 – Jun 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.7 to 1) · 1,666 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,973 patients answered, 18% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 4 |
| Recommend hospital | 4 |
| Room was "always" clean | 69% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 75% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 72% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 77% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 62% |
| "YES", patients would definitely recommend the hospital | 72% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$18,216
Medicare paid this office $18,216 for 67 people. Most of that is long return visits and Botox.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 36 | $6,955 | $107 |
| Long return visit (40+ min) | 45 | $6,667 | $90 |
| Telephone medical discussion with physician, 21-30 minutes | 11 | $776 | $71 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 21 | $692 | $20 |
| Advance care planning, first 30 minutes | 14 | $587 | $42 |
Who their Medicare patients are
67 Original Medicare patients in 2024. Average age 69 · Women 54% · Also on Medicaid 28% · Health risk score 3.09. Sicker patients than 9 in 10 peers; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 75% · Cancer 55% · Chronic kidney disease 37% · Depression 37% · COPD 25% · Diabetes 22% · Heart failure 21% · Coronary heart disease 19%.
The office billed $73,477, Medicare allowed $24,266 and paid $18,216; for 240 services of 9 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 67 | 240 | 69 | 3.09 | $73,477 | $18,216 |
| 2023 | 64 | 230 | 68 | 3.04 | $55,976 | $15,880 |
| 2022 | 27 | 55 | 66 | 2.54 | $14,713 | $4,076 |
| 2021 | 68 | 118 | 70 | 3.13 | $39,490 | $10,646 |
| 2020 | 11 | 16 | 68 | 1.57 | $4,746 | $1,340 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Long return visit (40+ min) | 40 | $6,870 | $93 |
| Long return visit (40+ min) | 21 | $3,711 | $93 |
| Return visit (30+ min) | 18 | $1,167 | $65 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 19 | $930 | $21 |
| Advance care planning, first 30 minutes | 11 | $602 | $50 |
2022: 1 service
| Long return visit (40+ min) | 12 | $1,480 | $99 |
2021: 2 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 49 | $5,086 | $67 |
| Critical care, first 30-74 minutes | 20 | $5,045 | $153 |
Medicaid work
$1,335 in 2024
Medicaid paid $1,335 for 39 billed services this clinician did in 2024, up to 13 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Long return visit (40+ min) | 39 | $1,335 |
| 2024 | 39 | 1 | 13 | $1,335 |
| 2023 | 98 | 1 | 18 | $2,679 |
See the largest Medicaid services in earlier years
2023
| Long return visit (40+ min) | 98 | $2,679 |
Drugs they prescribed that Part D paid
$104,567
Pharmacies billed $104,567 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 53% of their Part D prescriptions (709 of 1,346) in 2024. A higher opioid share than 9 in 10 peers; the typical nurse practitioner clinician is at 0%. Long-acting opioids: 36% of their opioid prescriptions.
1,242 generic and 104 brand-name prescriptions · $104,567 in drug cost · 15 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Xtampza Er | 42 | $33,261 | $792 |
| Oxycontin | 25 | $32,854 | $1,314 |
| Oxycodone | 205 | $7,304 | $36 |
| Fentanyl | 39 | $3,982 | $102 |
| Oxycodone-Acetaminophen | 115 | $3,707 | $32 |
See all 28 drugs
| Xtampza Er | 42 | $33,261 | $792 |
| Oxycontin | 25 | $32,854 | $1,314 |
| Oxycodone | 205 | $7,304 | $36 |
| Fentanyl | 39 | $3,982 | $102 |
| Oxycodone-Acetaminophen | 115 | $3,707 | $32 |
| Morphine Sulfate Er | 91 | $3,002 | $33 |
| Hydrocodone-Acetaminophen | 64 | $1,858 | $29 |
| Hydromorphone | 39 | $1,611 | $41 |
| Morphine Sulfate | 28 | $1,298 | $46 |
| Naloxone | 18 | $1,291 | $72 |
| Gabapentin | 82 | $1,271 | $16 |
| Methadone | 60 | $1,163 | $19 |
| Mirtazapine | 59 | $839 | $14 |
| Lidocaine Hcl Viscous | 13 | $524 | $40 |
| Lidocaine | 13 | $487 | $37 |
| Ondansetron Odt | 13 | $319 | $25 |
| Alprazolam | 47 | $217 | $5 |
| Methylphenidate | 14 | $213 | $15 |
| Olanzapine | 19 | $181 | $10 |
| Pantoprazole | 32 | $169 | $5 |
| Clonazepam | 21 | $153 | $7 |
| Escitalopram | 18 | $122 | $7 |
| Trazodone | 33 | $115 | $3 |
| Methocarbamol | 16 | $90 | $6 |
| Nortriptyline | 18 | $59 | $3 |
| Omeprazole | 15 | $39 | $3 |
| Quetiapine | 11 | $23 | $2 |
| Lorazepam | 13 | $20 | $2 |
Year by year
| 2024 | 1,346 | 162 | 53% (709) | 8% | $104,567 |
| 2023 | 1,194 | 124 | 60% (715) | 7% | $111,682 |
| 2022 | 452 | 81 | 50% (226) | None | $38,446 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 22 drugs
| Xtampza Er | 45 | $42,395 | $942 |
| Oxycontin | 20 | $24,859 | $1,243 |
| Oxycodone | 249 | $12,875 | $52 |
| Morphine Sulfate Er | 137 | $6,753 | $49 |
| Hydrocodone-Acetaminophen | 75 | $3,945 | $53 |
| Oxycodone-Acetaminophen | 78 | $3,585 | $46 |
| Fentanyl | 37 | $3,376 | $91 |
| Naloxone | 30 | $2,582 | $86 |
| Gabapentin | 79 | $1,610 | $20 |
| Methadone | 44 | $978 | $22 |
| Morphine Sulfate | 14 | $815 | $58 |
| Duloxetine | 19 | $463 | $24 |
| Hydromorphone | 13 | $457 | $35 |
| Clonazepam | 19 | $259 | $14 |
| Pantoprazole | 37 | $248 | $7 |
| Alprazolam | 35 | $245 | $7 |
| Ondansetron Odt | 11 | $201 | $18 |
| Escitalopram | 29 | $191 | $7 |
| Mirtazapine | 14 | $175 | $12 |
| Promethazine | 12 | $109 | $9 |
| Trazodone | 20 | $79 | $4 |
| Nortriptyline | 12 | $74 | $6 |
2022: 11 drugs
| Xtampza Er | 12 | $13,808 | $1,151 |
| Oxycodone | 86 | $4,378 | $51 |
| Morphine Sulfate Er | 40 | $2,198 | $55 |
| Hydrocodone-Acetaminophen | 36 | $1,334 | $37 |
| Gabapentin | 40 | $1,101 | $28 |
| Oxycodone-Acetaminophen | 17 | $858 | $50 |
| Methadone | 13 | $232 | $18 |
| Mirtazapine | 14 | $200 | $14 |
| Pantoprazole | 21 | $150 | $7 |
| Escitalopram | 11 | $83 | $8 |
| Trazodone | 16 | $71 | $4 |
Money from drug and device companies
$100 in 2022
A payment is not proof that care is biased.
| Gilead Sciences | Descovy | $100 | 1 payment
|
See the published payment
| Gilead Sciences | Meals · 2022-03-16 | Descovy | $100 |
Professional record
- NPI
- 1760092902
- Licence
- LA 215009
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Nurse practitioner (363L00000X); Federal specialty code 363LA2100X (363LA2100X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2020-08-03
- NPI last updated
- 2025-09-08
- NPI record certified
- 2025-09-08
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 1514 Jefferson Hwy, New Orleans, LA, 70121